Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Jul;60(7):2636–2640. doi: 10.1128/iai.60.7.2636-2640.1992

Murine model of cutaneous infection with gram-positive cocci.

C Bunce 1, L Wheeler 1, G Reed 1, J Musser 1, N Barg 1
PMCID: PMC257214  PMID: 1612733

Abstract

Staphylococcus aureus has remained an important cause of nosocomial wound infections, but standardized or reproducible systems for analyzing cutaneous infections caused by S. aureus do not exist. A variety of foreign materials, variable inocula, and skin traumas have been used to promote infection. To minimize these variables and ensure reproducibility, we chose a model using subcutaneous injections of a fixed quantity of dextran microbeads (Cytodex) as the foreign material added to standardized broth suspensions of S. aureus. Suspensions (0.2 ml) injected into an outbred strain of immunocompetent hairless mice generated reproducible, measurable lesions. With S. aureus Smith Diffuse, fluctuant, erythematous lesions with a peak diameter of 15 mm were observed; these lesions yielded purulent material containing gram-positive cocci and neutrophils and yielded growth of S. aureus on culture. Lesion size was proportional to the bacterial inoculum size. Histologic examination of excised lesions revealed typical abscesses. A second strain of S. aureus (SLC3) produced dermonecrosis instead of abscesses at an inoculum size of 10(7) CFU. Control injections with a sterile Cytodex suspension regularly produced nondraining, nonerythematous nodules with maximum diameters of less than or equal to 5 mm. Streptococcus pyogenes produced late-onset necrotic lesions and abscesses. Using a foreign substance, this model generates easily observed and reproducible cutaneous infection with S. aureus and streptococci that can potentially discriminate between inter- and intrastrain differences. Such a model could be used to test the pathogenicity of isogeneic strains of these bacterial species and to evaluate the efficacy of antimicrobial agents.

Full text

PDF
2636

Images in this article

2637Image
on p.2637
2637Image
on p.2637
2638Image
on p.2638

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albus A., Arbeit R. D., Lee J. C. Virulence of Staphylococcus aureus mutants altered in type 5 capsule production. Infect Immun. 1991 Mar;59(3):1008–1014. doi: 10.1128/iai.59.3.1008-1014.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bor D. H., Rose R. M., Modlin J. F., Weintraub R., Friedland G. H. Mediastinitis after cardiovascular surgery. Rev Infect Dis. 1983 Sep-Oct;5(5):885–897. doi: 10.1093/clinids/5.5.885. [DOI] [PubMed] [Google Scholar]
  3. Bramley A. J., Patel A. H., O'Reilly M., Foster R., Foster T. J. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun. 1989 Aug;57(8):2489–2494. doi: 10.1128/iai.57.8.2489-2494.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dye E. S., Kapral F. A. Characterization of a bactericidal lipid developing within staphylococcal abscesses. Infect Immun. 1981 Apr;32(1):98–104. doi: 10.1128/iai.32.1.98-104.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ELEK S. D., CONEN P. E. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol. 1957 Dec;38(6):573–586. [PMC free article] [PubMed] [Google Scholar]
  6. Ford C. W., Hamel J. C., Stapert D., Yancey R. J. Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. J Med Microbiol. 1989 Apr;28(4):259–266. doi: 10.1099/00222615-28-4-259. [DOI] [PubMed] [Google Scholar]
  7. Fujimoto T., Sato M., Katami K., Osada Y., Tsumura M., Tachizawa H., Une T. Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice. Chemotherapy. 1986;32(3):291–298. doi: 10.1159/000238426. [DOI] [PubMed] [Google Scholar]
  8. Gerding D. N., Bean B., Peterson L. R., Moody J., Bettin K. Cephalothin clearance of Staphylococcus aureus from two experimental infection sites in the presence and absence of local phagocytic cells. J Antimicrob Chemother. 1987 Nov;20(5):685–695. doi: 10.1093/jac/20.5.685. [DOI] [PubMed] [Google Scholar]
  9. Iandolo J. J. Genetic analysis of extracellular toxins of Staphylococcus aureus. Annu Rev Microbiol. 1989;43:375–402. doi: 10.1146/annurev.mi.43.100189.002111. [DOI] [PubMed] [Google Scholar]
  10. Jonsson P., Lindberg M., Haraldsson I., Wadström T. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect Immun. 1985 Sep;49(3):765–769. doi: 10.1128/iai.49.3.765-769.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kinsman O. S., Arbuthnott J. P. Experimental staphylococcal infections in newborn mice: inhibition of weight gain as an index of virulence. J Med Microbiol. 1980 May;13(2):281–290. doi: 10.1099/00222615-13-2-281. [DOI] [PubMed] [Google Scholar]
  12. Kraft W. G., Johnson P. T., David B. C., Morgan D. R. Cutaneous infection in normal and immunocompromised mice. Infect Immun. 1986 Jun;52(3):707–713. doi: 10.1128/iai.52.3.707-713.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee J. C., Betley M. J., Hopkins C. A., Perez N. E., Pier G. B. Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsule size. J Infect Dis. 1987 Nov;156(5):741–750. doi: 10.1093/infdis/156.5.741. [DOI] [PubMed] [Google Scholar]
  14. McMurray L. W., Kernodle D. S., Barg N. L. Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections. J Infect Dis. 1990 Sep;162(3):759–762. doi: 10.1093/infdis/162.3.759. [DOI] [PubMed] [Google Scholar]
  15. Musser J. M., Hauser A. R., Kim M. H., Schlievert P. M., Nelson K., Selander R. K. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668–2672. doi: 10.1073/pnas.88.7.2668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. O'Reilly M., de Azavedo J. C., Kennedy S., Foster T. J. Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. Microb Pathog. 1986 Apr;1(2):125–138. doi: 10.1016/0882-4010(86)90015-x. [DOI] [PubMed] [Google Scholar]
  17. Onderdonk A. B., Cisneros R. L., Finberg R., Crabb J. H., Kasper D. L. Animal model system for studying virulence of and host response to Bacteroides fragilis. Rev Infect Dis. 1990 Jan-Feb;12 (Suppl 2):S169–S177. doi: 10.1093/clinids/12.supplement_2.s169. [DOI] [PubMed] [Google Scholar]
  18. Patel A. H., Nowlan P., Weavers E. D., Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun. 1987 Dec;55(12):3103–3110. doi: 10.1128/iai.55.12.3103-3110.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Renneberg J., Walder M. The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin. J Infect Dis. 1989 Aug;160(2):337–341. doi: 10.1093/infdis/160.2.337. [DOI] [PubMed] [Google Scholar]
  20. Rossi R., Castellani P., Younes G., Della Bruna C. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice. J Antimicrob Chemother. 1989 Mar;23 (Suppl 100):149–155. doi: 10.1093/jac/23.suppl_c.149. [DOI] [PubMed] [Google Scholar]
  21. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  22. Seki K., Ogasawara M., Sakurada J., Murai M., Masuda S. Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice. Microbiol Immunol. 1989;33(12):981–990. doi: 10.1111/j.1348-0421.1989.tb03156.x. [DOI] [PubMed] [Google Scholar]
  23. Sherertz R. J., Forman D. M., Solomon D. D. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother. 1989 Aug;33(8):1174–1178. doi: 10.1128/aac.33.8.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yoshida K., Takahashi M. Colonial morphologies of the Smith diffuse strain of Staphylococcus aureus related to mouse virulence. Jpn J Microbiol. 1973 Jul;17(4):321–322. doi: 10.1111/j.1348-0421.1973.tb00781.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES